16-71850065-A-G
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_001137675.4(ATXN1L):āc.325A>Gā(p.Thr109Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000238 in 1,551,616 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001137675.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ATXN1L | NM_001137675.4 | c.325A>G | p.Thr109Ala | missense_variant | 3/3 | ENST00000427980.7 | NP_001131147.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ATXN1L | ENST00000427980.7 | c.325A>G | p.Thr109Ala | missense_variant | 3/3 | 1 | NM_001137675.4 | ENSP00000415822 | P1 | |
ATXN1L | ENST00000683775.1 | c.325A>G | p.Thr109Ala | missense_variant | 3/3 | ENSP00000507897 | P1 | |||
IST1 | ENST00000568581.5 | c.-16+1994A>G | intron_variant | 5 | ENSP00000456200 | |||||
ATXN1L | ENST00000569119.1 | n.119+1994A>G | intron_variant, non_coding_transcript_variant | 5 |
Frequencies
GnomAD3 genomes AF: 0.0000592 AC: 9AN: 152074Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000110 AC: 17AN: 154122Hom.: 0 AF XY: 0.0000978 AC XY: 8AN XY: 81768
GnomAD4 exome AF: 0.0000200 AC: 28AN: 1399424Hom.: 0 Cov.: 30 AF XY: 0.0000232 AC XY: 16AN XY: 690218
GnomAD4 genome AF: 0.0000591 AC: 9AN: 152192Hom.: 0 Cov.: 32 AF XY: 0.0000806 AC XY: 6AN XY: 74408
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 11, 2022 | The c.325A>G (p.T109A) alteration is located in exon 3 (coding exon 1) of the ATXN1L gene. This alteration results from a A to G substitution at nucleotide position 325, causing the threonine (T) at amino acid position 109 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at